Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 4 of 43 for:    Open Studies | "Sarcoidosis"

Worldwide Sarcoidosis Research Study (WISE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2012 by University of Iowa
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Alicia Gerke, University of Iowa
ClinicalTrials.gov Identifier:
NCT01610843
First received: May 31, 2012
Last updated: November 5, 2014
Last verified: May 2012
  Purpose

The aim of this study is to collect information about the clinical course and characteristics of sarcoidosis patients around the world through web-based surveys. Recruitment is directed at and driven by patients in the sarcoidosis community. This will allow the the investigators to study sarcoidosis patients across all demographic, geographic, and socioeconomic boundaries, not just patients seen at large research centers. The investigators believe this study can give investigators a broader and less biased view of sarcoidosis. The investigators would also like to collect genetic samples on this population to assess genetic variance in different phenotypes.

The information for the study would be provided through a web based survey system that can be accessed by patients or physicians of patients from any computer with Internet access. This system would collect clinical information in sufficient detail so that the phenotype of individual patients can be evaluated. Upon agreeing to participate in further research studies through the website, subjects will also have the opportunity to provide a DNA sample.


Condition
Sarcoidosis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Worldwide Sarcoidosis Research Study

Resource links provided by NLM:


Further study details as provided by University of Iowa:

Primary Outcome Measures:
  • Define and characterize sarcoidosis phenotypes and methods of care [ Time Frame: Anticipated by 2017 ] [ Designated as safety issue: No ]
    To give a broader and less biased view of sarcoidosis


Biospecimen Retention:   Samples With DNA

Saliva samples will be collected and processed at the University of Iowa.


Estimated Enrollment: 10000
Study Start Date: December 2011
Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Individuals diagnosed with sarcoidosis who have a computer with Internet access.

Criteria

Inclusion Criteria:

  • Diagnosis of Sarcoidosis
  • Access to a computer with Internet

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01610843

Contacts
Contact: Alicia K Gerke, MD 319-356-1869 alicia-gerke@uiowa.edu
Contact: Emily K Phillips, BSN 319-356-1869 emily-phillips@uiowa.edu

Locations
United States, Iowa
University of Iowa Recruiting
Iowa City, Iowa, United States, 52242
Contact: Alicia K Gerke, MD    319-356-1869    alicia-gerke@uiowa.edu   
Sub-Investigator: Alicia K Gerke, MD         
Sponsors and Collaborators
University of Iowa
Investigators
Principal Investigator: Alicia K Gerke, MD University of Iowa
  More Information

Additional Information:
Publications:

Responsible Party: Alicia Gerke, Assistant Professor; Division of Pulmonary, Critial Care and Occupational Medicine, University of Iowa
ClinicalTrials.gov Identifier: NCT01610843     History of Changes
Other Study ID Numbers: 200907757, 5UL1RR024979
Study First Received: May 31, 2012
Last Updated: November 5, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by University of Iowa:
Sarcoidosis
WISE
Sarcoid Study
Worldwide Sarcoidosis Research Study

Additional relevant MeSH terms:
Sarcoidosis
Lymphatic Diseases
Lymphoproliferative Disorders

ClinicalTrials.gov processed this record on November 25, 2014